News & Updates

In the first-line treatment of locally advanced or metastatic esophageal squamous cell carcinoma (ESCC), adding the anti-PD-1 monoclonal antibody toripalimab to a standard chemotherapy regimen can significantly cut the risk of progression or death without an increase in adverse events, according to the prespecified analysis of the phase III JUPITER-06 trial.

No clinical association exists between predefined genomic risk score and testosterone level in men undergoing radical prostatectomy, according to a study.

In a study evaluating individuals without diabetes, increasing the overall level of physical activity was associated with reduced glucose maximum peaks the following day.

Combining alprostadil with conventional treatment appears to lead to a more effective improvement in renal function among patients with hypertensive nephropathy, reports a recent meta-analysis.

Treatment with a nonhallucinogenic phytocannabinoid, cannabidivarin, is well tolerated in children with Rett syndrome (RTT), according to data from a phase 1 trial. Moreover, it improves seizure control in those whose disease is caused by methyl-CpG-binding protein 2 (MECP2) pathogenic variants.